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Considerable variations were found in the in vitro effect of alloxan on mouse liver enzymes associated with 
the citric acid cycle. The following approximative alloxan concentrations induced 50% inhibition of enzyme 
activity: 10m6 M for aconitase, lo-’ M for NAD-linked isocitrate dehydrogenase, glutamate dehydrogenase, 
a-ketoglutarate dehydrogenase, succinyl-CoA synthetase and fumarase, and 10m3 M for citrate synthase and 
NADP-linked isocitrate dehydrogenase. Pyruvate dehydrogenase, succinate dehydrogenase and malate de- 
hydrogenase were not inhibited by 10m3 M alloxan. The inhibition of aconitase was competitive both when 
using mouse liver and purified porcine heart enzyme. The K, values for the purified enzyme in the presence 
of 5 PM alloxan were 0.22 PM with citrate, 4.0 PM with cis-aconitate and 0.62 PM with isocitrate as sub- 
strate. The high sensitivity of aconitase for inhibition by alloxan probably plays a prominent role for the 
toxic effects of alloxan. 
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1. INTRODUCTION 
Alloxan is taken up in vivo and in vitro in 
mitochondria of different mouse organs, including 
those from the endocrine pancreas which show 
significantly highest in vivo uptake [1,2], and af- 
fects different mitochondrial functions, e.g., the 
accumulation and retention of different ions 
[3-51. Isolated mouse liver mitochondria in- 
cubated with alloxan exhibit enhanced state 4 
respiration with succinate and inhibited state 4 
respiration with pyridine-linked substrates, 
whereas state 3 respiration is decreased with both 
kinds of substrates [5]. Moreover, inhibition of the 
oxidation of pyridine-linked substrates, but unaf- 
fected or only slightly decreased oxidation of suc- 
cinate has been observed in mouse islets isolated 
10 min following the injection of alloxan [6], and 
in rat kidney homogenate exposed to alloxan in 
vitro [7]. 
pyruvate dehydrogenase and the enzymes directly 
associated with the citric acid cycle, this work was 
initiated to study whether alloxan affects the ac- 
tivity of those enzymes. The activities of the 
pyruvate, succinate and malate dehydrogenases 
were not affected by alloxan, whereas most other 
enzymes investigated were inhibited, the inhibition 
being especially marked for aconitase which for 
this reason was studied in more detail. 
2. METHODS 
The enzyme activities were determined in 
sonically disrupted isolated liver mitochondria of 
3-4-month-old C57BL-KsJ - + / + mice of either 
sex, starved for 21 h. Additionally purified 
aconitase from porcine heart (Sigma, St Louis, 
MO) was used. The determinations were carried 
out at 25°C. 
Since divergent effects of alloxan on FAD- 
linked and pyridine-linked respiration inter alia 
might be due to different inhibitory influences on 
Fe’+ and reductants activate aconitase [8]. Based 
on pilot experiments performed because reductants 
might affect the action of alloxan [4], 1 mM Fe’+ 
and 50pM cysteine were chosen for activation. 
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Since those experiments showed high activity of 
aconitase in fresh mitochondrial preparations not 
treated with Fe*+ or reductant, non-activated 
aconitase activity was also studied to avoid the 
possible interaction of reductants with the in- 
hibitory effects of alloxan. Corrections were made 
for the influence of alloxan on the determinations 
at 232, 235 and 240 nm. 
The aconitase activity was measured by follow- 
ing the appearance and disappearance of cis- 
aconitate at 240 nm with citrate, cis-aconitate and 
isocitrate as substrates [9]. Fumarate formation 
was similarly studied at 240 nm [9]. NAD- and 
NADP-linked isocitrate dehydrogenase, and 
glutamate, a-ketoglutarate, malate and pyruvate 
dehydrogenases were all measured by following the 
reduction of pyridine nucleotides at 340 nm; the 
measurement of a-ketoglutarate dehydrogenase 
being carried out after ultracentrifugation at 
120000 x g for 1 h in the presence of CoA, and the 
measurement of pyruvate dehydrogenase being 
carried out in the presence of CoA and thiamine 
pyrophosphate, all additions made at a concentra- 
tion of 1 mM [lo]. The activity of citrate synthase 
was determined at 232 nm [ll], that of succinyl- 
CoA synthetase was followed at 235 nm [12] and 
that of succinate dehydrogenase was studied at 
600 nm [13]. 
3. RESULTS AND DISCUSSION 
Determination of the concentration of alloxan 
inducing 50% inhibition of different mitochon- 
drial enzymes showed that aconitase was inhibited 
at a concentration of 10e6 M, whereas higher con- 
centrations were needed for inhibition of citrate 
synthase, succinyl-CoA synthetase, and the NAD- 
and NADP-linked isocitrate and the glutamate, cy- 
ketoglutarate and malate dehydrogenases (table 1). 
The activities of the succinate, malate and 
pyruvate dehydrogenases were not at all inhibited 
at concentrations of alloxan up to 1O-3 M. 
These data are consistent with the finding that 
alloxan inhibits the respiration with glutamate plus 
malate in isolated liver mitochondria [5], and the 
oxidation of some pyridine-linked substrates by 
kidney homogenates [7], and prevents the raise in 
oxygen uptake in isolated pancreatic islets after ad- 
dition of glucose, citrate or oxaloacetate [6]. The 
present data also agree with the observation that 
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rather high concentrations of alloxan are needed 
for induction of changes in the handling of ions, 
membrane potential and volume of isolated liver 
and islet mitochondria when the substrate is suc- 
cinate [3-51, whereas lower concentrations of 
alloxan induce such changes when pyridine-linked 
substrates are used (unpublished). 
Since the data presented in table 1 indicated that 
aconitase was especially sensitive to inhibition by 
alloxan, this inhibition was studied more 
thoroughly. Both when using mouse liver 
mitochondrial aconitase and the purified enzyme 
from porcine heart, alloxan behaved essentially as 
a competitive inhibitor regardless of the substrate 
(figs 1 and 2). The Ki values for the different 
substrates in the presence of 5 PM alloxan show 
that the reaction started with cis-aconitate is less 
Table 1 
Concentrations of alloxan inducing 50% inhibition of 
the activity of enzymes associated with the citric acid 
cycle of mouse liver mitochondria 
Enzyme Substrate Alloxan 
concentration 
(M) 
Citrate synthase 
Aconitase 
Aconitase 
Aconitase 
NAD-linked 
isocitrate 
dehydrogenase 
NADP-linked 
isocitrate 
dehydrogenase 
Glutamate 
dehydrogenase 
a-Ketoglutarate 
dehydrogenase 
Succinyl-CoA 
synthetase 
Succinate 
dehydrogenase 
Fumarase 
Malate 
dehydrogenase 
Pyruvate 
dehydrogenase 
oxaloacetate 
citrate 
cis-aconitate 
isocitrate 
isocitrate 
isocitrate 
glutamate 
cu-ketoglutarate 
succinate 
succinate 
malate 
oxaloacetate 
pyruvate 
8.5 x 1O-4 
6.9 x 1O-6 
2.8 x 1O-5 
9.2 x 1O-6 
1.5 x 1o-4 
1.2 x 10-3 
3.8 x 1O-4 
2.8 x 1O-4 
3.2 x 1O-4 
no inhibition” 
1.4 x 1o-4 
no inhibitionb 
no inhibitionb 
a Highest concentration studied: 5 mM 
b Highest concentration studied: 1 mM 
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Fig.1. Lineweaver-Burk plot of porcine heart aconitase 
in the absence (0-0) and presence (+---o) of 5 pM 
alloxan. 
sensitive to inhibition by alloxan than that started 
with either citrate or isocitrate (table 2). The Km 
and Ki values for the inhibition of the purified en- 
zyme were not very different from the apparent K,,, 
and Ki values for the liver mitochondrial enzyme. 
No significant difference in inhibitory effect of 
alloxan was found between activated and non- 
activated aconitase. 
The reason why the aconitase reaction starting 
with cis-aconitate is less sensitive to inhibition by 
alloxan than that starting with citrate or isocitrate 
is not known. A similar difference has been 
,_--, 
0.5 1.0 
[cl t rate] mM-1 
1.5 
Fig.2. Lineweaver-Burk plot of aconitase activity in 
mouse liver mitochondria in the absence (m) and 
presence (o--o) of 5 PM alloxan. 
reported for fluorocitrate [ 14- 161, which 
represents a potent aconitase inhibitor. That dif- 
ference has been suggested to be due to a greater 
affinity of cis-aconitate for the enzyme than the 
enzyme affinity of citrate or isocitrate [14,15]. 
Since a simple binding of inhibitor to enzyme 
would be expected to give the same Ki value 
regardless of the substrate, the present Ki values 
may indicate a complex interaction between 
aconitase and alloxan, which is well known to 
react, e.g., with thiol groups and metal ions. 
The Ki values obtained indicate that alloxan, 
compared with other known inhibitors [17], is a 
very potent inhibitor of mitochondrial aconitase. 
Table 2 
Kinetic values for activated purified porcine aconitase and apparent values for mouse liver mitochondrial 
aconitase 
Substrate Purified porcine aconitase 
Km (mM) k cat Ki @M) 
(mkat . kg-‘) 
Mouse aconitase 
Km (mM) k cat K, (uW 
(mkat . kg-‘) 
Citrate 3.3 92 0.22 3.0 2.4 1.1 
cis-Aconitate 0.12 76 4.0 - - - 
Isocitrate 0.88 132 0.62 0.90 3.9 0.92 
5 PM alloxan was used for determination of Ki. The values represent the means of data obtained from 
Lineweaver-Burk and Eadie-Hofstee plots and direct computerized calculation 
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Our early electron microscopic studies of the 
insulin-producing cells in the pancreas of mice in- 
jected with alloxan suggested that alloxan diabetes 
might be due to mitochondrial damage [18,19], 
and subsequent biochemical investigations sup- 
ported this opinion [l-5]. The present data in- 
dicate that the primary target for the toxic action 
of alloxan may be mitochondrial aconitase. In- 
terestingly, there are a few reports of disturbed 
glucose metabolism, hyperglycemia nd ketonemia 
in animals in which aconitase has been inhibited by 
fluorocitrate [20,21], although other symptoms 
predominate in fluorocitrate poisoning. 
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